reduced the turnaround time for results of various tests, facilitating rapid decision-making and possibly better quality of care. The blood gas analysis (BGA) is POC technology that is able to provide crucial information such as electrolytes, acid-base status, and hemoglobin, within 10-12 minutes. 4 Besides the advantage of rapid turnaround time, the BGA also minimizes the number of pre-analytic steps and involves significantly less volume of blood. However, there are key differences in how the blood sample is processed and analyzed in BGA machines as compared to the AA in central biochemistry laboratories, for instance, the separation of serum and pre-analytic dilution in AA. 2 An understanding of differences, if any, in results of the same test performed on these machines and their clinical relevance, would be crucial to ascertain the implications in clinical decisionmaking. The existing literature comparing these tests yielded mixed results and use of small sample sizes, study population, and method of sampling may have contributed to the discrepancy. [5] [6] [7] [8] [9] We tested the hypothesis that results of the same test performed on BGA machine and AA machine have high degree of concordance
in an unselected population of critical care patients and that the two test methods could be used interchangeably. To test this hypothesis, we retrospectively analyzed the concordance between the electrolyte and hemoglobin values obtained from these two test methods using the largest sample size reported to date.
| MATERIAL S AND ME THODS
The study was a retrospective observational study, conducted on patients admitted to mixed medical and surgical intensive care 
| Analysis
Study sample size was primarily based on sodium concentrations, as our previous study revealed the significance of this electrolyte in morbidity and mortality in critically ill patients. 10 A sample of 100 paired specimens was analyzed. The mean (SD) of sodium in BGA and AA was 138.23 (5.33) and 138.02 (5.25), respectively, with average difference (bias) of 0.22. The sample size based on these differences at α of 0.05 and β of 0.20 was 9078 paired specimens.
We determined the agreement between the results obtained by the AA and BGA methods using concordance correlation coefficient (CCC) 11 and Bland-Altman analysis. 12 It is customary in such agreement analyses to use paired t tests (to test significant differences between means), Pitman's test (to test significant differences between variances), and Bradley-Blackwood F test (to simultaneously test for significant differences between means and variances). However, these tests are sensitive to large sample sizes and yield significant differences due to small standard errors resulting from large sample sizes. We therefore did not conduct these tests of significance and, instead, reported the results as 95% confidence intervals (CI) for the CCC. Multivariate outlier detection method 13 was used to limit the analyses to meaningful numbers.
Additionally, result pairs with at least one hemoglobin result less than 70 g/L were analyzed for agreement between the two test methods. A test result of less than 70 g/L was regarded as an indication for blood transfusion. 14 The difference in results from the two test methods was also assessed against the United States Clinical Laboratory Improvement Amendments (US-CLIA) 88 rules, 15 according to which the following variations are considered as acceptable: chloride ±5%; glucose ±10%; sodium ±4.0 mmol/L; hemoglobin ±7%; potassium ±0.5 mmol/L.
There were no available performance criteria on bicarbonate.
The test results were considered to be interchangeable if they were within the US-CLIA variability criteria and would not alter the clinical management when compared to each other. All analyses were performed using SPSS version 21 (IBM Corp., Armonk, NY, USA).
| RE SULTS
A total of 9398 matched pairs of BGA and AA results were obtained for analysis from 1765 patients. The median (IQR) time interval between sampling for BGA and AA in each result pair was 5 (3-10)
minutes. 
| D ISCUSS I ON
There was good concordance between the two test methods, with low bias. The LOA relative to bias was relatively large for sodium and chloride, with 3.4% and 5.2% readings lying outside the US-CLIA variability limits, respectively. Also the bias for hemoglobin was largest with 5.9% readings outside the US-CLIA limits. Only for potassium concentration, the two tests yielded similar, interchangeable results.
The LOA and bias were concerning for sodium and hemoglobin, respectively, and this may have implications for clinical practice.
Sodium levels if outside the normal range are associated with high morbidity and mortality. 10 Furthermore, if they are not corrected gradually and carefully, the associated morbidity is significant. 16 This necessitates repeated sodium measurements during correction.
Given the wide limits of agreement relative to the small bias, it will be a safer practice to either follow BGA alone or AA alone to guide treatment and they should not be used interchangeably. Although only 3.4% of pairs were outside the US-CLIA limit of 4 mmol/L, this limit appears to be clinically significant as this limit approximates the safe maximum acceptable change per day in sodium concentrations in high-risk patients. 16 Also varying sodium levels may distort the calculated anion gap, a measure frequently used in critically ill patients. 5 The findings are similar to previous studies. 5, 7, 9, 17, 18 Similar to sodium, the limits of agreement were large relative to the bias for chloride; however, the impact of such degree of discrepancy on clinical practice is not clear.
The bias for potassium was only 0.09, which is the lowest reported in literature (0.1-0.7 mmol/L). 2 Also only 1.6% of the readings were outside the US-CLIA variability limits. The bias is well acknowledged as the potassium is released from platelets during clotting. 2 This small degree of bias and the fact that majority of readings were within the acceptable variation, suggests that for practical purposes, the two tests yield similar results.
The bias was largest for hemoglobin levels. BGA. This overestimation by BGA has been observed in previous studies. 19 The blood glucose had small bias and limits of agreement; however, there were two observations of concern. Firstly, 7.1% of readings by the two methods were outside the US-CLIA variability limits, and secondly, the difference between the BGA and AA increased above 10 mmol, with BGA tending to overestimate blood glucose levels. In critically ill patient, blood glucose levels are generally controlled to less than 10 mmol/L. The reason behind this differential agreement between the two tests is not clear.
The above observations in sodium and hemoglobin levels may be explained by number of factors. High proportion of critically ill patients have protein levels outside normal range. 20 The indirect ion-specific electrode employed in AA has been shown to be more susceptible to effects of protein levels, thereby altering the and such syringes can thereby introduce different degrees of bias when the levels of positively charged ions are being measured. 21, 22 Other factors that may contribute to differences include sample transport, dilution of serum samples prior to testing, and variations in instrument calibration. This may have implications while calculating anion gap in critically ill patients.
5
There are some notable limitations of this study. Firstly, our study did not explore the pre-analytical process of using POCT machine which would impact on the quality of results as previously reported. 24 The analysis of factors, such as plasma proteins, leukocyte count, arterial vs venous sample, sample collection, and handling, may help explain the observed biases and limits of agreement. Another limitation which is present in several other studies is unavoidable due to retrospective design, and due to pragmatic reasons, is the time difference between the sampling for the two tests.
Treatment interventions such as fluid resuscitation or blood transfusion may alter the agreement between the two tests. The median time interval was only 5 minutes in our study, and the large sample size to certain extent would have diluted this error. However, this
should be controlled for in future study, with ideally the tests performed on the same blood sample procured from the patient.
We conclude that there is moderate to substantial concordance between the central laboratory AA and BGA machines on tests performed in critically ill patients. However, the two tests methods cannot be used interchangeably, except for potassium. For clinical practice such as following analyte trends and measuring beforeafter concentrations during clinical intervention, using the same test method is important.
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